← back to search

Eliah Aronoff‐Spencer

University of California San Diego · US
Area of research
Molecular Biology · General Health Professions
Research interest
Research interests include Advanced biosensing and bioanalysis techniques, Mobile Health and mHealth Applications, SARS-CoV-2 detection and testing, and Telemedicine and Telehealth Implementation.
h-index
24
citations
3,953
works
87
NIH funding
primary concept
email

Recent publications

Real-World Use of Control-IQ Technology Is Associated with a Lower Rate of Severe Hypoglycemia and Diabetic Ketoacidosis Than Historical Data: Results of the Control-IQ Observational (CLIO) Prospective Study
Diabetes Technology & Therapeutics 2023cited by 40position: lastdoi
Hitting the diagnostic sweet spot: Point-of-care SARS-CoV-2 salivary antigen testing with an off-the-shelf glucometer
Biosensors and Bioelectronics 2021cited by 107position: middledoi
Recognition and management of community-acquired acute kidney injury in low-resource settings in the ISN 0by25 trial: A multi-country feasibility study
PLoS Medicine 2021cited by 65position: middledoi
Designing a Framework for Remote Cancer Care Through Community Co-design: Participatory Development Study
Journal of Medical Internet Research 2021cited by 24position: firstdoi
A Risk-Based Clinical Decision Support System for Patient-Specific Antimicrobial Therapy (iBiogram): Design and Retrospective Analysis
Journal of Medical Internet Research 2021cited by 18position: lastdoi
A comprehensive assessment for community-based, person-centered care for older adults
BMC Geriatrics 2020cited by 25position: firstdoi
Differential pressure control of 3D printed soft fluidic actuators
2017cited by 72position: middledoi
Lyophilized visually readable loop-mediated isothermal reverse transcriptase nucleic acid amplification test for detection Ebola Zaire RNA
Journal of Virological Methods 2017cited by 63position: lastdoi
Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional study
The Lancet 2016cited by 430position: middledoi
Detection of Hepatitis C core antibody by dual-affinity yeast chimera and smartphone-based electrochemical sensing
Biosensors and Bioelectronics 2016cited by 85position: firstdoi
International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology
The Lancet 2015cited by 1,124position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ravindra L. Mehta · University of California San Diego3 papers (2015–2021) · 3 papers (2015–2021)Nathan W. Levin · Renal Research Institute3 papers (2015–2021) · 3 papers (2015–2021) · 3 papers (2015–2021)Giuseppe Remuzzi · Mario Negri Institute for Pharmacological Research3 papers (2015–2021)Marcello Tonelli · Institute of Public Health Zadar3 papers (2015–2021)Vivekanand Jha · Rajamangala Institute of kidney disease3 papers (2015–2021)Drew A. Hall · University of California San Diego3 papers (2016–2021)Jorge Cerdá · St Thomas' Hospital3 papers (2015–2021) · 3 papers (2015–2021)John Feehally · University of Leicester3 papers (2015–2021)Michael V. Rocco · Wake Forest University3 papers (2015–2021) · 3 papers (2015–2021)Fredric O. Finkelstein · Yale University2 papers (2015–2021)Etienne Macedo · University of San Diego2 papers (2016–2021)Gregory J. Norman · Dexcom (United States)1 papers (2020–2020)Christoph C Carter · Gilead Sciences (United States)1 papers (2017–2017)Bertrand L. Jaber · Tufts University1 papers (2015–2015) · 1 papers (2021–2021)